Results from the Phase III TEMPLE trial show that patients administered Qulipta (atogepant) experienced significantly fewer ...

Primary outcomes included relapse rates and time to relapse, with secondary outcomes including cognitive deficits, treatment response (the proportion of patients with≥1 point improvement in mRS within ...

Ask the publishers to restore access to 500,000+ books. The Internet Archive keeps the record straight by preserving government websites, news publications, historical documents, and more. If you find ...